CH582157A5 - - Google Patents
Info
- Publication number
- CH582157A5 CH582157A5 CH444876A CH444876A CH582157A5 CH 582157 A5 CH582157 A5 CH 582157A5 CH 444876 A CH444876 A CH 444876A CH 444876 A CH444876 A CH 444876A CH 582157 A5 CH582157 A5 CH 582157A5
- Authority
- CH
- Switzerland
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/186,444 US3954758A (en) | 1970-05-27 | 1971-10-04 | Process for fluorinating uracil and derivatives thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH582157A5 true CH582157A5 (enExample) | 1976-11-30 |
Family
ID=22684987
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH225372A CH577981A5 (enExample) | 1971-10-04 | 1972-02-16 | |
| CH444876A CH582157A5 (enExample) | 1971-10-04 | 1972-02-16 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH225372A CH577981A5 (enExample) | 1971-10-04 | 1972-02-16 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US4113949A (enExample) |
| JP (1) | JPS5328433B2 (enExample) |
| CA (1) | CA991178A (enExample) |
| CH (2) | CH577981A5 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5572366U (enExample) * | 1978-11-08 | 1980-05-19 | ||
| DE3441524A1 (de) * | 1984-11-14 | 1986-05-15 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung von 5-fluorcytosin |
| US20030194693A1 (en) * | 2002-02-25 | 2003-10-16 | Oksman Alexander Y. | Method of prevention of lysosomal leakage in eukaryotic cells by using 6-methyluracil based water-soluble compounds and method of producing thereof |
| TWI589609B (zh) | 2016-12-22 | 2017-07-01 | 財團法人工業技術研究院 | 高分子與分散液 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3277092A (en) * | 1963-05-02 | 1966-10-04 | Hoffmann La Roche | 5, 6-substituted dihydro-5-fluoropyrimidines |
| US3360523A (en) * | 1964-06-17 | 1967-12-26 | Du Pont | 3, 5, 6-substituted hydrouracils |
| US3669970A (en) * | 1970-03-17 | 1972-06-13 | American Cyanamid Co | 3,5,6-substituted-6-(trifluoromethyl)-hydrouracils |
-
1972
- 1972-01-19 CA CA132,791A patent/CA991178A/en not_active Expired
- 1972-02-16 CH CH225372A patent/CH577981A5/xx not_active IP Right Cessation
- 1972-02-16 CH CH444876A patent/CH582157A5/xx not_active IP Right Cessation
- 1972-03-22 JP JP2818272A patent/JPS5328433B2/ja not_active Expired
-
1976
- 1976-03-11 US US05/665,865 patent/US4113949A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA991178A (en) | 1976-06-15 |
| JPS5328433B2 (enExample) | 1978-08-15 |
| JPS4844268A (enExample) | 1973-06-26 |
| CH577981A5 (enExample) | 1976-07-30 |
| US4113949A (en) | 1978-09-12 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased | ||
| PL | Patent ceased |